3,127 results on '"Davies AN"'
Search Results
2. Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial
3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
4. A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults
5. Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria
6. A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation–associated TMA
7. Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial
8. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
9. Quercetin ameliorates XIAP deficiency–associated hyperinflammation
10. Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis
11. Retinoic acid–responsive CD8 effector T cells are selectively increased in IL-23–rich tissue in gastrointestinal GVHD
12. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency
13. Somatic Hypermutation in Enhancer Regions Shapes Non-Coding Myeloma Genome, Generating DNA Breaks and Driving Etiology through Mutation and Structural Variation
14. Young and Distinct: Clinical Characteristics and Outcomes of Patients 50 or Younger with Multiple Myeloma
15. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome
16. Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival
17. A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
18. Toward personalized treatment in multiple myeloma based on molecular characteristics
19. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia
20. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
21. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
22. Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy
23. Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study
24. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD
25. Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers
26. Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
27. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status
28. Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children
29. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study
30. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma
31. A Randomized, Placebo-Controlled, Phase 1 Study in Healthy Adult Volunteers of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN303, a Potent Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Cytopenias
32. Follicular Lymphoma Treatment Patterns and Outcomes over Time: A Real-World Analysis in the United States
33. Genomic Determinants of Resistance in Newly Diagnosed Multiple Myeloma Treated with Targeted-Immunotherapy
34. Tracking the Earliest Genomic Events in Multiple Myeloma Life-History
35. Fc-Mediated Antibody Effector Function, Inflammation Resolution and Oligoclonality on TCR Rearrangements Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Treated with Immunotherapy Regimens
36. Five-Year Survival Results from the Remodl-B Trial (ISRCTN 51837425) Show Improved Outcomes in Diffuse Large B-Cell Lymphoma Molecular Subgroups from the Addition of Bortezomib to R-CHOP Chemoimmunotherapy
37. Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial
38. Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma
39. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin
40. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
41. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
42. IL-4 enhances expression and function of surface IgM in CLL cells
43. The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy
44. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
45. Alemtuzumab levels impact acute GVHD, mixed chimerism, and lymphocyte recovery following alemtuzumab, fludarabine, and melphalan RIC HCT
46. Redefining nonmeasurable multiple myeloma using mass spectrometry
47. EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
48. Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations
49. Genomic profiling for clinical decision making in lymphoid neoplasms
50. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.